World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
32350
World Ranking
8973
National Ranking
4618

Overview

James M. Ford is affiliated with Stanford University in the United States. Their work spans multiple fields related to medicine, biochemistry, genetics, and molecular biology, with a strong focus on oncology.

Areas of study prominently addressed in their research include:

  • Oncology
  • Molecular Biology
  • Cancer Research
  • Genetics
  • Pathology and Forensic Medicine

The main research topics covered by James M. Ford are:

  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • BRCA gene mutations in cancer
  • PARP inhibition in cancer therapy
  • DNA Repair Mechanisms
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Treatments and Studies

Frequent publication venues for Ford include:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Oncology
  • Nature Cancer
  • Clinical Cancer Research

James M. Ford has collaborated extensively with several coauthors, including:

  • Meredith Mills
  • M Snyder
  • Uri Ladabaum
  • Edward D. Esplin
  • Allison W. Kurian

Selected recent papers authored or coauthored by Ford include:

  • The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution (2020, Cell)
  • Hereditary diffuse gastric cancer: updated clinical practice guidelines (2020, The Lancet Oncology)
  • Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer (2022, Annals of Oncology)
  • Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer (2022, Nature Genetics)
  • Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study (2023, The Lancet Oncology)

Best Publications

  • Pharmacology of drugs that alter multidrug resistance in cancer.

    J M Ford;W N Hait

  • Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

    Melinda L. Telli;Kirsten M. Timms;Julia Reid;Bryan Hennessy

  • American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

    Mark E. Robson;Mark E. Robson;Angela R. Bradbury;Banu K Arun;Susan M. Domchek

  • Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair

    Byung Joon Hwang;James M. Ford;Philip C. Hanawalt;Gilbert Chu

  • Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines

    Ashley A. Powell;AmirAli H. Talasaz;Haiyu Zhang;Marc A. Coram

  • Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

    Rachel S van der Post;Ingrid P Vogelaar;Fátima Carneiro;Parry Guilford

  • p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes.

    Martin L. Smith;James M. Ford;M. Christine Hollander;Rachel A. Bortnick

  • The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution

    Orit Rozenblatt-Rosen;Aviv Regev;Aviv Regev;Aviv Regev;Philipp Oberdoerffer;Tal Nawy

  • Clinical Interpretation and Implications of Whole-Genome Sequencing

    Frederick E. Dewey;Megan E. Grove;Cuiping Pan;Benjamin A. Goldstein

  • Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer.

    Albert C Koong;Quynh T Le;Anthony Ho;Bryan Fong

  • Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

    Allison W. Kurian;Emily E. Hare;Meredith A. Mills;Kerry E. Kingham

  • Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer

    Pardeep Kaurah;Andrée MacMillan;Niki Boyd;Janine Senz

  • Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

    A R Brooks-Wilson;P Kaurah;G Suriano;S Leach

  • Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance

    James M. Ford;Philip C. Hanawalt

  • Expression of Wild-type p53 Is Required for Efficient Global Genomic Nucleotide Excision Repair in UV-irradiated Human Fibroblasts

    James M. Ford;Philip C. Hanawalt

  • Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.

    Daniel T. Chang;Devin Schellenberg;John Shen;Jeff Kim

  • p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene.

    Shanthi Adimoolam;James M. Ford

  • Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

    Albert C. Koong;Erin Christofferson;Quynh Thu Le;Karyn A. Goodman

  • Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis.

    Jean Y Tang;Byung Joon Hwang;James M Ford;Philip C Hanawalt

  • Founder and Recurrent CDH1 mutations in families with Hereditary diffuse gastric Cancer. Editorial

    Pardeep Kaurah;Andrée Macmillan;Niki Boyd;Janine Senz

Frequent Co-Authors

Allison W. Kurian
Allison W. Kurian Stanford University
Jeffrey A. Norton
Jeffrey A. Norton Stanford University
Albert C. Koong
Albert C. Koong The University of Texas MD Anderson Cancer Center
Stephen B. Gruber
Stephen B. Gruber City Of Hope National Medical Center
Teri A. Longacre
Teri A. Longacre Stanford University
Dee W. West
Dee W. West Stanford University
Judy Garber
Judy Garber Harvard University
Philip C. Hanawalt
Philip C. Hanawalt Stanford University
Mark E. Robson
Mark E. Robson Memorial Sloan Kettering Cancer Center
Michael Snyder
Michael Snyder Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA can open doors to a wide variety of online degrees and healthcare careers. For those interested in the administrative side of healthcare, enrolling in a online medical coding classes with financial aid can be an affordable way to start working in medical billing and coding roles, which are in high demand across hospitals and clinics.

Nursing offers flexible options too. Many prospective students wonder: do you have to take a teas test for lpn? Fortunately, some nursing schools waive this requirement, helping you streamline your path to becoming a Licensed Practical Nurse (LPN).

For those drawn to healthcare leadership, pursuing a healthcare administration associate degree online offers a fast-track into management positions overseeing medical facilities and patient care systems. Registered nurses hoping to advance further might consider adn to fnp bridge programs, which allow RNs with an associate degree to transition efficiently to roles as Family Nurse Practitioners.

With these flexible study options and career pathways, a fulfilling future in healthcare may be more accessible than ever—whether you're beginning your journey or looking to advance your credentials online.

Best Scientists Citing James M. Ford

Trending Scientists

Recently Published Articles